SCR-LIP-000203 · Claim · machine-readable JSON →
Noninvasive 3T MR lymphangiography revealed distinct topographic patterns of subcutaneous adipose tissue hyperintensity (extravascular and vascular) that distinguished lipedema, lipedema-with-lymphedema, and cancer-related lymphedema from BMI-matched controls, with cancer lymphedema showing more frequent dilated vascular patterns (OR=12.27) and diffuse hyperintensity observed only in disease groups, supporting imaging-based differentiation.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 4 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T MR Lymphangiography — Crescenzi et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
The study directly applies MR lymphangiography and Dixon fat/water MRI to compare imaging patterns across lipedema, lymphedema, LWL and controls, reporting group differences and odds ratios; however interobserver agreement was only fair-to- [grade capped moderate->low per curated Oxford N4]
Context (PECO)
Answers these questions
- Is lipedema a distinct disease, separate from obesity and lymphedema? consistent
- Can MRI, lymphoscintigraphy, or DXA differentiate lipedema from lymphedema and other fat distributions? consistent
- Can MRI differentiate lipedema from lymphedema and other fat distributions? consistent
- Can lymphoscintigraphy differentiate lipedema from lymphedema? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-06-02 — merged · absorbed duplicate SCR-LIP-000072
- 2026-05-31 — created · auto-ingested for SQ-LIP-000023